Domů › Rakovina prsu › Ohio › Columbus
Klinické studie Rakovina prsu v Columbus, OH
39 studií pro Rakovina prsu hledá účastníky v lokalitách v Columbus a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- The Mark H Zangmeister Center, Columbus
- a dalších 8
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Probíhá náborFáze 2
- The Ohio State University, Stefanie Spielman Comprehensive Breast Center, Columbus
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
Probíhá náborFáze 1
- James Cancer Hospital and Solove Research Institute, Columbus
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Probíhá náborFáze 1/2
- Local Institution - 0102, Columbus
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Probíhá náborFáze 3
- Clinical Trial Site, Columbus
- Clinical Trial Site, Columbus
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Probíhá náborFáze 3
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
Probíhá náborFáze 1
- The Mark H. Zangmeister Center-Mid Ohio Oncology/Hematology, Inc., Columbus
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Probíhá náborFáze 1
- The Ohio State University (OSU) Wexner Medical Center, Columbus
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Probíhá náborFáze 3
- Ohio State University Comprehensive Cancer Center, Columbus
- Columbus Oncology and Hematology Associates Inc, Columbus
- Riverside Methodist Hospital, Columbus
- a dalších 8
ATEMPT 2.0: Adjuvant T-DM1 vs TH
Probíhá náborFáze 2
- Stefanie Spielman Comprehensive Breast Center, Columbus
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Probíhá náborFáze 3
- Ohio State University Comprehensive Cancer Center, Columbus
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
Probíhá náborFáze 2Vítáni zdraví dobrovolníci
- Ohio State University Comprehensive Cancer Center, Columbus
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Probíhá náborFáze 1/2
- Ohio State University Comprehensive Cancer Center (OSUCCC)- The James Cancer Hospital and Solove Research Institute, Columbus
E-Mindfulness Approaches for Living After Breast Cancer
Probíhá náborFáze 3
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- Mount Carmel Grove City Hospital, Grove City · Vzdálenost 7 mi
- a dalších 2
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Probíhá náborFáze 2
- The Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Probíhá náborFáze 1/2
- Stefanie Spielman Comprehensive Breast Center, Columbus
Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)
Probíhá náborFáze 4
- Ohio State University Comprehensive Cancer Center, Columbus
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
Probíhá náborFáze 2
- Ohio State University Comprehensive Cancer Center, Columbus
A Pilot Study to Evaluate the Effectiveness of Focused Massage on Pain, Mobility, and Quality of Life During Radiation Treatment for Patients With Breast Cancer
Probíhá nábor
- The Ohio State University, Columbus
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Probíhá náborFáze 3
- The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solovev Research Institute (OSUCCC - , Columbus
Impact of Dietary Inflammatory Potential on Breast Cancer Risk
Probíhá náborObservační studie
- Ohio State University Comprehensive Cancer Center, Columbus
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
Probíhá náborFáze 1
- Ohio State University-James Cancer Hospital and Solove Research Institute, Columbus
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease
Probíhá náborFáze 2
- Ohio State University, Stefanie Spielman Comprehensive Breast Center, Columbus
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Probíhá náborFáze 3
- Stefanie Spielman Comprehensive Breast Center at Olentangy River Road, Columbus
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Probíhá náborFáze 2
- The Ohio State University, Stefanie Spielman Comprehensive Breast Center, Columbus
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
Probíhá náborFáze 2
- Ohio State University Medical Center, Columbus
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Probíhá náborFáze 3
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- Riverside Methodist Hospital, Columbus
- a dalších 8
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
Probíhá náborObservační studie
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Probíhá náborFáze 1/2
- Stefanie Spielman Comprehensive Breast Center, Columbus
Living Well With Advanced Breast Cancer
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- Ohio State University Comprehensive Cancer Center, Columbus
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Probíhá náborObservační studie
- Memorial Hospital, Marysville · Vzdálenost 27 mi
Feasibility Study of CBCT for IGRT in Cancer Patients
Probíhá nábor
- James Outpatient Center, Columbus
- Ohio State University, Brain and Spine Hospital, Columbus
- The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus
- a dalších 1
The Sleep After Breast Cancer (ABC) Study - Examining Sleep Changes and Biomarkers Among Breast Cancer Patients
Probíhá náborObservační studie
- Ohio State University Comprehensive Cancer Center, Columbus
The Ohio State University (OSU) SCREEN Community Program
Probíhá náborVítáni zdraví dobrovolníci
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Probíhá náborFáze 1/2
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY
Probíhá náborFáze 2
- The Ohio State University, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Probíhá náborObservační studie
- Massive Bio SYNERGY-AI site, Columbus
Pilot Study of a MIND Diet Intervention in Women Undergoing Active Treatment for Breast Cancer
Probíhá nábor
- Ohio State University Comprehensive Cancer Center, Columbus
IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry
Probíhá náborObservační studie
- Mount Carmel West Hospital, Columbus
Studie Rakovina prsu v jiných městech
- New York City, NY134 studií
- Houston, TX126 studií
- Boston, MA111 studií
- Nashville, TN80 studií
- Los Angeles, CA72 studií
- Edison, NJ68 studií
- St. Louis, MO64 studií
- Durham, NC63 studií
- Queens, NY63 studií
- Chicago, IL58 studií
- Philadelphia, PA56 studií
- Dallas, TX55 studií
Další studie v Columbus
- Nemalobuněčný plicní karcinom56 studií
- Rakovina vaječníků39 studií
- Rakovina (všechny typy)38 studií
- Rakovina plic37 studií
- Akutní myeloidní leukemie35 studií
- Chronická lymfocytární leukemie28 studií
- Metastatický karcinom27 studií
- Rakovina endometria25 studií
- Kolorektální karcinom24 studií
- Rakovina prostaty24 studií
- Mnohočetný myelom24 studií
- Melanom21 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.